Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

10 treatments under study, led by Vaccinations

Research Leaders

10 sponsors active, led by Bill and Melinda Gates Foundation

Related Conditions

Often studied with 12 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed5

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 5 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT06820710Not ApplicableCompleted

Multidomain Interventions for Elderly Individuals in Residential Structures

NCT05302908Not ApplicableCompleted

COVID-19 Testing and Vaccination Among Spanish Speakers

NCT05329506CompletedPrimary

Attitudes and Believes About Vaccinations in a Supportive Care Patient Population

NCT03975517Completed

Sexual Risks in Prep Users

NCT03428776Not ApplicableCompletedPrimary

Timeliness of Immunization and Compliance Assessment Study

Showing all 5 trials

Research Network

Common Treatments

  • Vaccinations1
  • Record Keeping1
  • Standard Compliancelinked Incentives1
  • Cognitive Stimulation1
  • Nutritional Intervention1

Active Sponsors

  • Bill and Melinda Gates Foundation1
  • St. Louis University1
  • University Hospital, Strasbourg, France1
  • Wake Forest University Health Sciences1
  • Royal Datamatics Pvt. Ltd. (RDPL), India1

Top Investigators

Related Conditions

  • Aging1
  • Hiv Infection1
  • Nutritional Intervention1
  • Long Term Care Facility1
  • Cognitive Training1

Activity Timeline